Clinical and Molecular Hepatology (대한간학회지)

The Korean Association for the Study of the Liver (대한간학회)
권호 표지
DOI QR코드

DOI QR Code

${\beta}$-catenin activated hepatocellular adenoma

  • Chu, Hyun Hee (Department of Pathology and Research Institute for Endocrine Science, Chonbuk National University Medical School) ;
  • Moon, Woo Sung (Department of Pathology and Research Institute for Endocrine Science, Chonbuk National University Medical School)
  • Published : 2013.06.25
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Bioulac-Sage P, Balabaud C, Wanless I. Focal nodular hyperplasia and hepatocellular adenoma. In: Bosman F, Carneiro F, Hruban R, Theise ND, eds. WHO Classification of Tumours of the Digestive System, 4th Ed. Lyon, France: IARC Press, 2010:198-204.
  2. Velazquez I, Alter BP. Androgens and liver tumors: Fanconi's anemia and non-Fanconi's conditions. Am J Hematol 2004;77:257-267. https://doi.org/10.1002/ajh.20183
  3. Bioulac-Sage P, Rebouissou S, Thomas C, Blanc JF, Saric J, Sa Cunha A, et al. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology 2007;46:740-748. https://doi.org/10.1002/hep.21743
  4. Bioulac-Sage P, Cubel G, Balabaud C. Pathological diagnosis of hepatocellular adenoma in clinical practice. Diagnostic Histopathology 2011;17:521-529. https://doi.org/10.1016/j.mpdhp.2011.10.007
  5. Bioulac-Sage P, Laumonier H, Couchy G, Le Bail B, Sa Cunha A, Rullier A, et al. Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience. Hepatology 2009;50:481-489. https://doi.org/10.1002/hep.22995
  6. Micchelli ST, Vivekanandan P, Boitnott JK, Pawlik TM, Choti MA, Torbenson M. Malignant transformation of hepatic adenomas. Mod Pathol 2008;21:491-497. https://doi.org/10.1038/modpathol.2008.8
  7. Zucman-Rossi J, Jeannot E, Nhieu JT, Scoazec JY, Guettier C, Rebouissou S, et al. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology 2006;43:515-524. https://doi.org/10.1002/hep.21068
  8. van Aalten SM, Verheij J, Terkivatan T, Dwarkasing RS, de Man RA, Ijzermans JN. Validation of a liver adenoma classification system in a tertiary referral centre: implications for clinical practice. J Hepatol 2011;55:120-125. https://doi.org/10.1016/j.jhep.2010.10.030
  9. Van der Borght S, Libbrecht L, Katoonizadeh A, Aerts R, Nevens F, Verslype C, et al. Nuclear beta-catenin staining and absence of steatosis are indicators of hepatocellular adenomas with an increased risk of malignancy. Histopathology 2007;51:855-856. https://doi.org/10.1111/j.1365-2559.2007.02862.x
  10. Bioulac-Sage P, Cubel G, Balabaud C, Zucman-Rossi J. Revisiting the pathology of resected benign hepatocellular nodules using new immunohistochemical markers. Semin Liver Dis 2011;31:91-103. https://doi.org/10.1055/s-0031-1272837
  11. Laumonier H, Bioulac-Sage P, Laurent C, Zucman-Rossi J, Balabaud C, Trillaud H. Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification. Hepatology 2008;48:808-818. https://doi.org/10.1002/hep.22417

Cited by

  1. Evolution of Hepatic Steatosis to Fibrosis and Adenoma Formation in Liver-Specific Growth Hormone Receptor Knockout Mice vol.5, pp.None, 2013, https://doi.org/10.3389/fendo.2014.00218
  2. Atypical β-Catenin Activated Child Hepatocellular Tumor vol.18, pp.2, 2013, https://doi.org/10.5223/pghn.2015.18.2.144